Research peptide retailer (US parent, UK subdomain)
Direct Peptides UK
Lab not named
UK-localised subdomain of US-headquartered Direct Peptides (trademark held by Aspire Labs, Texas). Broadest format coverage in the UK segment: lyophilised vials, pre-mixed pens, nasal-spray stacks, capsules, topical cosmetic peptides. 8 years trading (since ~2017). 20 percent first-order discount on dedicated /first-order/ page.
Headline price
BPC-157 £11.46 to £189.22 (volume tiers per SKU)
Regulated as
US parent (Aspire Labs, Texas), no UK Companies House registration
Delivery area
UK plus worldwide
Certificate of Analysis profile
CoA per batch
Unverified
Access
unverified
Lab
Third-party GMP-inspected ISO9001 facility (unnamed) -- site states: 'The facility we work with regularly undergoes routine Good Manufacturing Process (GMP) inspection, and it is also ISO 9001 certified... produced in a facility owned by one of the world's top leaders of protein mimicry' (no specific lab/facility named)
QR-verifiable
No
Trust Index status
CoA: weak / closed10/100 · D
Founded
2017
Companies House
17180450
Business Transparency
Confirmed
Last verified
2026-08-19
- ⚠ US parent, no UK Companies House registration
- ⚠ Sells peptides in capsule or tablet form, which is oral dosing by design
- ⚠ Publishes benefit claims next to products despite research-only framing
Re-checked on a rolling basis, not a fixed monthly cycle; see the last-verified date above. See methodology for how this is scored.
Separate from the CoA score
Responsible Practice assessment
Material concerns- · Consumer Q&A format ('Can BPC-157 capsules support...') aimed at a buyer of an oral capsule product, not a literature summary.
- · Benefit-claim language observed on site: "Can BPC‑157 capsules support gastrointestinal mucosal integrity and gut barrier function? Oral BPC‑157 has been evaluated in models of gastric ulcers, colitis, and gut permeability, where it has shown protective and pro‑healing effects on the mucosal lining. This includes support for epithelial regeneration and potential reduction of inflammatory damage to the gastrointestinal tract."
We assess what a brand publishes and makes available to customers, not its intentions. Full framework and what each status means: how we assess brands. Think this is wrong? Email [email protected] with evidence.
Not yet Independently Verified
The CoA tier and Responsible Practice status above are free and mechanical. Nobody, including Direct Peptides UK, has paid for the deeper lab-accreditation, batch-traceability, and corporate-history checks yet. Request that it be run →
Named bundles and stacks
Best for
Buyers wanting the broadest catalogue of delivery formats (vials + pens + nasals + capsules + topicals) in the UK segment.
Weak on
US-domiciled brand using a UK subdomain. No COA gallery, no batch QR. Returns and recourse flow through US parent.
What stands out
- · Broadest delivery-format catalogue: vials, pre-mixed pens, nasal-spray stacks, capsules
- · Dedicated topical cosmetic peptide lane (Matrixyl, Acetyl-Hexapeptide-3, AHK-Cu, Decapeptide-12 etc.)
- · Multi-currency switcher
- · Live chat (LiveChat.com) site-wide
- · 20 percent first-order discount on dedicated /first-order/ landing page
- · Minimum 98 percent purity (some products 99 percent)
Useful pages on Direct Peptides UK
Our verdict
Best for delivery-format breadth (pens, nasals, capsules) in the UK segment. Trade-off is the US-parent structure with no UK corporate identity, which weakens recourse versus UK-registered operators.
Last reviewed 2026-08-19. PeptideClear earns nothing when readers click through, and this link carries no tracking. Editorial criteria are documented in our methodology.
Ready to start?
Visit Direct Peptides UK →
No commission earned. Untracked link, direct to Direct Peptides UK.